New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Caladrius Biosciences, Inc.
CLBS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3M

Biotechnology

0.43USD
Shape-0.09 ( -16.75%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

NaN%

Quote Panel

Shape
Updated October 12, 2024
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    3.35M


  • Shares Outstanding

    7.86M


  • Share in Float

    6.51M


  • Dividende

    0.56


  • Earning Date

    No Data


  • Price Target

    0.4264


  • Average Volume


  • Beta

    0.913304


  • Range


  • Industry

    Biotechnology


  • Website

    https://www.caladrius.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.07x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.4

EPS

How CLBS compares to sector?

P/E Ratio

Relative Strength

Shape

CLBS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.20

arrow
arrow

N/A

-0.38
vs -0.44

Q2.20

arrow
arrow

+202%

0.5
vs -0.49

Q3.20

arrow
arrow

N/A

-4.35
vs -0.47

Q4.20

arrow
arrow

N/A

-4.20
vs -0.47

Q1.21

arrow
arrow

N/A

-2.85
vs -0.38

Q2.21

arrow
arrow

N/A

-1.50
vs 0.5

Q3.21

arrow
arrow

N/A

-1.80
vs -4.35

Q4.21

arrow
arrow

N/A

-1.65
vs -4.20

Q1.22

arrow
arrow

N/A

-1.05
vs -2.85

Q2.22

arrow
arrow

N/A

-1.65
vs -1.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.20

arrow
arrow

NA

NA  vs NA

Q2.20

arrow
arrow

NA

NA  vs NA

Q3.20

arrow
arrow

NA

NA  vs NA

Q4.20

arrow
arrow

-53%

25.2M  vs 53.2M

Q1.21

arrow
arrow

NA

NA  vs NA

Q2.21

arrow
arrow

NA

NA  vs NA

Q3.21

arrow
arrow

NA

NA  vs NA

Q4.21

arrow
arrow

+398%

125.6M  vs 25.2M

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.20

arrow
arrow

-14%

-0.14
vs 0.2

Q4.20

arrow
arrow

-17%

-0.17
vs -0.14

Q1.21

arrow
arrow

-7%

-0.07
vs -0.17

Q2.21

arrow
arrow

-5%

-0.05
vs -0.07

Q3.21

arrow
arrow

-7%

-0.07
vs -0.05

Q4.21

arrow
arrow

-7%

-0.07
vs -0.07

Q1.22

arrow
arrow

-5%

-0.05
vs -0.07

Q2.22

arrow
arrow

-8%

-0.08
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q4.20

arrow
arrow

30

30
vs 30

NA

Q1.21

arrow
arrow

35

35
vs 30

17%

Q2.21

arrow
arrow

28

28
vs 35

-20%

Q3.21

arrow
arrow

34

34
vs 28

21%

Q4.21

arrow
arrow

32

32
vs 34

-6%

Q1.22

arrow
arrow

32

32
vs 32

NA

Q2.22

arrow
arrow

31

31
vs 32

-3%

Q3.22

arrow
arrow

1

1
vs 31

-97%

Earnings Growth

Latest News